8-K
filed March 13, 2024, 7:59 PM ET
ticker MIRA
CIK 0001904286
leadership
confidence high
sentiment neutral
materiality 0.60
Mira Pharmaceuticals board overhaul: 4 resignations, new directors, CSO replaced by advisor
MIRA PHARMACEUTICALS, INC.
- Directors Talhia Tuck, Brad Kroenig, Hugh McColl resigned March 9; Chairman Chris Chapman resigned to focus on Telomir Pharma.
- New board: CEO Erez Aminov named Chairman; Dr. Matthew Del Giudice, Dr. Denil Shekhat, Ned MacPherson appointed.
- President & CSO Dr. Adam Kaplin resigned March 7; company hired Dr. Itzchak Angel as Chief Scientific Advisor via APCT.
- Dr. Angel has 30+ yrs pharma experience, helped develop Ambien, Xatral; will assist with IND preparation and regulatory affairs.
- Restructuring aims to strengthen clinical/regulatory expertise for future IND filing for product candidate.
Key facts
Extracted from this filing and checked against the source text.
Executive change
SEC 8-K Item 5.02
confidence 0.95
Matthew P. Del Giudice was appointed as Director at MIRA PHARMACEUTICALS, INC..
- Action
- appointed
- Role
- Director
Exact text from the filing
On March 13, 2024, the remaining members of the Board (Erez Aminov and Michael Jerman) unanimously approved the appointment of (i) Mr. Aminov, the Company’s Chief Executive Officer, as Chairman of the Board and (ii) Dr. Matthew P. Del Giudice, Dr. Denil N. Shekhat and Mr. Ned MacPherson as members of the Board, to fill the vacancies on the Board occasioned by the resignations from the Board described above
View on SEC.gov
Executive change
SEC 8-K Item 5.02
confidence 0.95
Hugh McColl resigned as Director at MIRA PHARMACEUTICALS, INC..
- Action
- resigned
- Role
- Director
Exact text from the filing
Ms. Talhia Tuck, Mr. Brad Kroenig and Mr. Hugh McColl, each voluntarily resigned from the Board, effective immediately.
View on SEC.gov
Executive change
SEC 8-K Item 5.02
confidence 0.95
Chris Chapman resigned as Executive Chairman at MIRA PHARMACEUTICALS, INC..
- Action
- resigned
- Role
- Executive Chairman
Exact text from the filing
Also on March 9, 2024, Dr. Chris Chapman notified the Board and senior Company management of his resignation both as Executive Chairman and as an employee of the Company, effective immediately, citing his desire to focus his time on his role as Chairman and Chief Executive Officer of Telomir Pharmaceuticals, Inc.
View on SEC.gov
Executive change
SEC 8-K Item 5.02
confidence 0.95
Ned MacPherson was appointed as Director at MIRA PHARMACEUTICALS, INC..
- Action
- appointed
- Role
- Director
Exact text from the filing
On March 13, 2024, the remaining members of the Board (Erez Aminov and Michael Jerman) unanimously approved the appointment of (i) Mr. Aminov, the Company’s Chief Executive Officer, as Chairman of the Board and (ii) Dr. Matthew P. Del Giudice, Dr. Denil N. Shekhat and Mr. Ned MacPherson as members of the Board, to fill the vacancies on the Board occasioned by the resignations from the Board described above
View on SEC.gov
Executive change
SEC 8-K Item 5.02
confidence 0.95
Erez Aminov was appointed as Chairman of the Board at MIRA PHARMACEUTICALS, INC..
- Action
- appointed
- Role
- Chairman of the Board
Exact text from the filing
On March 13, 2024, the remaining members of the Board (Erez Aminov and Michael Jerman) unanimously approved the appointment of (i) Mr. Aminov, the Company’s Chief Executive Officer, as Chairman of the Board and (ii) Dr. Matthew P. Del Giudice, Dr. Denil N. Shekhat and Mr. Ned MacPherson as members of the Board, to fill the vacancies on the Board occasioned by the resignations from the Board described above
View on SEC.gov
Executive change
SEC 8-K Item 5.02
confidence 0.95
Brad Kroenig resigned as Director at MIRA PHARMACEUTICALS, INC..
- Action
- resigned
- Role
- Director
Exact text from the filing
Ms. Talhia Tuck, Mr. Brad Kroenig and Mr. Hugh McColl, each voluntarily resigned from the Board, effective immediately.
View on SEC.gov
Executive change
SEC 8-K Item 5.02
confidence 0.95
Denil N. Shekhat was appointed as Director at MIRA PHARMACEUTICALS, INC..
- Action
- appointed
- Role
- Director
Exact text from the filing
On March 13, 2024, the remaining members of the Board (Erez Aminov and Michael Jerman) unanimously approved the appointment of (i) Mr. Aminov, the Company’s Chief Executive Officer, as Chairman of the Board and (ii) Dr. Matthew P. Del Giudice, Dr. Denil N. Shekhat and Mr. Ned MacPherson as members of the Board, to fill the vacancies on the Board occasioned by the resignations from the Board described above
View on SEC.gov
Executive change
SEC 8-K Item 5.02
confidence 0.95
Talhia Tuck resigned as Director at MIRA PHARMACEUTICALS, INC..
- Action
- resigned
- Role
- Director
Exact text from the filing
Ms. Talhia Tuck, Mr. Brad Kroenig and Mr. Hugh McColl, each voluntarily resigned from the Board, effective immediately.
View on SEC.gov
This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice.
See methodology for how this pipeline works.